16 hours ago
References
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
23andMe sells gene-testing business to DNA drug maker Regeneron

23andMe and its user data will soon belong to a pharmaceutical giant

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

Struggling DNA testing firm 23andMe to be bought for $256m

Pharma giant Regeneron to buy 23andMe and its customers' data for $256M | TechCrunch

Bankrupt DNA Company 23andMe Expected to Be Purchased for $256M: What Users Need to Know About Their Privacy
:max_bytes(150000):strip_icc():focal(368x300:370x302)/23andMe-Regeneron-051925-7ac2b643e5984f4fb5745184ba619565.jpg)
Regeneron Buys 23andMe in Bankruptcy Auction
:max_bytes(150000):strip_icc()/GettyImages-2206338240-bedb93720ad24fce94951c160cf3faac.jpg)
Why Regeneron is buying 23andMe

Can I Delete My 23andMe DNA? Everything to Know as Firm Sells to Regeneron

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

Biotech company Regeneron to buy bankrupt 23andMe for $256M

23andMe Sold To Biotechnology Company For $256 Million

0 Comments
Be the first to comment
Add your thoughts and get the conversation going.
Related Articles
Explore Your Interests
Create an account and enjoy content that interests you with your personalized feed
Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.